LH

美国控股实验室
NYSE

实时行情|Nasdaq Last Sale

116.17
-10.22
-8.09%
盘后: 116.17 0 0.00% 17:03 04/01 EDT
开盘
119.81
昨收
126.39
最高
120.37
最低
114.31
成交量
136.15万
成交额
--
52周最高
196.36
52周最低
98.02
市值
113.03亿
市盈率(TTM)
13.87
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测LH价格均价为193.07,最高价位225.00,最低价为163.00。

EPS

LH 新闻

更多
  • A Sliding Share Price Has Us Looking At Laboratory Corporation of America Holdings's (NYSE:LH) P/E Ratio
  • Simply Wall St. · 6小时前
  • Don't Get Bled By Lab Corp.
  • Seeking Alpha - Article · 8小时前
  • 3 Stocks Testing The Coronavirus
  • Zacks · 2天前
  • Wells Fargo Maintains Overweight on Laboratory Corp, Lowers Price Target to $170
  • Benzinga · 2天前

所属板块

医疗设施与服务
-3.84%
医疗保健提供商与服务
-4.36%

热门股票

代码
价格
涨跌幅

LH 简况

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.
展开

微牛提供Laboratory Corp. of America Holdings(NYSE-LH)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的LH股票新闻,以帮助您做出投资决策。